SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.

Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, Xu J

DOI: 10.1038/onc.2015.494
Published: 2016 Aug 18
Container: Oncogene
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/onc.2015.494,
  title = {SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.},
  author = {Sun Y and Zhu D and Chen F and Qian M and Wei H and Chen W and Xu J},
  year = {2016},
  journal = {Oncogene},
  doi = {10.1038/onc.2015.494},
  url = {https://doi.org/10.1038/onc.2015.494}
}

RIS

TY  - JOUR
TI  - SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.
AU  - Sun Y
AU  - Zhu D
AU  - Chen F
AU  - Qian M
AU  - Wei H
AU  - Chen W
AU  - Xu J
PY  - 2016
JO  - Oncogene
DO  - 10.1038/onc.2015.494
UR  - https://doi.org/10.1038/onc.2015.494
ER  -

APA

Y, S., D, Z., F, C., M, Q., H, W., W, C., & J, X. (2016). SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.. Oncogene. https://doi.org/10.1038/onc.2015.494

Source records

pubmed · retrieved 2026-09-25T00:32:14.379Z